5-AMINO-1MQ

Is an oral NNMT inhibitor that targets fat metabolism at the cellular level rather than acting through appetite suppression. By blocking the NNMT enzyme, which is overexpressed in adipose tissue, it increases intracellular NAD+, activates SIRT1, and shifts fat cells away from storage mode. Animal studies have shown significant reductions in fat mass without dietary changes. A powerful complement to GLP-1 peptides, targeting fat loss from a completely different biological pathway.